Genesis & Conrol of Lyme Disease by Innate Immunity

创世纪

基本信息

  • 批准号:
    7023910
  • 负责人:
  • 金额:
    $ 39.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-03-01 至 2009-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lyme disease, due to infection with the spirochete Borrelia burgdorferi (Bb), is the most common vector-borne disease in the United States. The disease occurs in stages and is largely due to the host immune response to the spirochete as it adapts to persist in the mammalian host. Innate immunity is provides the first line of defense against spirochete invasion and is critical for the induction of protective adaptive immune responses. Members of the Toll-like receptor (TLR) family of pattern recognition molecules allow innate immune cells to recognize and respond to Bb components. Although essential for host defense, innate immunity also gives rise to the immunopathology of Bb-associated disease. This proposal is based on our recent findings that absence of MyD88, an intracellular adaptor molecule required for TLR-induced inflammation, does not eliminate disease in Bb-infected mice, but severely impairs the ability of the host to control infection despite strong humoral immunity. The objectives of this proposal are to 1) determine the mechanisms through which Bb activates innate immune cells in vitro in the absence of MyD88-dependent TLR signaling; 2) define the defect in innate and/or adaptive immune response that leads to uncontrolled pathogen expansion in MyD88-deficient mice; 3) using double knock-out mice, determine the contribution of antibody, Fc receptors and l complement in MyD88-independent disease expression; 4) using RNA interference and conditional mutant mice, define the role of MyD88-dependent TLR responses in the control of Bb in the persistent phase of Bb infection; and 4) using Bb gene arrays, determine gene expression of spirochetes that persist in the antibody-responsive host. The results of these studies will provide new insight into the pathways utilized by innate immunity to recognize and respond to Bb and other extracellular pathogens. Understanding the contribution of these pathways to induction of inflammation may suggest new targets for therapeutic intervention or for enhancing immunity in inflammatory disorders, both infectious and non-infectious in origin. For the field of Lyme disease, defining the key molecules expressed by host-adapted spirochetes will move us one step closer toward understanding how this pathogen persists in an immunologically responsive host.
描述(由申请人提供):莱姆病是由伯氏疏螺旋体(Bb)感染引起的,是美国最常见的媒介传播疾病。该病分阶段发生,主要是由于宿主对螺旋体的免疫反应,因为它适应在哺乳动物宿主中持续存在。先天免疫是抵御螺旋体入侵的第一道防线,对诱导保护性适应性免疫反应至关重要。toll样受体(TLR)家族的模式识别分子允许先天免疫细胞识别Bb成分并作出反应。先天免疫虽然对宿主防御至关重要,但也会引起bb相关疾病的免疫病理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda K. Bockenstedt其他文献

Ballistic Motion of Spirochete Membrane Proteins
  • DOI:
    10.1016/j.bpj.2010.12.3013
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Holger Kress;Rostislav Boltyanskiy;Alexia A. Belperron;Cecile O. Mejean;Charles W. Wolgemuth;Linda K. Bockenstedt;Eric R. Dufresne
  • 通讯作者:
    Eric R. Dufresne

Linda K. Bockenstedt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda K. Bockenstedt', 18)}}的其他基金

Immunophenotypic analysis of the cutaneous humoral response in early Lyme disease
早期莱姆病皮肤体液反应的免疫表型分析
  • 批准号:
    10451111
  • 财政年份:
    2022
  • 资助金额:
    $ 39.91万
  • 项目类别:
Immunophenotypic analysis of the cutaneous humoral response in early Lyme disease
早期莱姆病皮肤体液反应的免疫表型分析
  • 批准号:
    10561695
  • 财政年份:
    2022
  • 资助金额:
    $ 39.91万
  • 项目类别:
Pathogenesis of Borrelia miyamotoi infection and Lyme coinfection in mice
小鼠宫本疏螺旋体感染和莱姆病合并感染的发病机制
  • 批准号:
    10059164
  • 财政年份:
    2017
  • 资助金额:
    $ 39.91万
  • 项目类别:
Pathogenesis of Borrelia miyamotoi infection and Lyme coinfection in mice
小鼠宫本疏螺旋体感染和莱姆病合并感染的发病机制
  • 批准号:
    10303049
  • 财政年份:
    2017
  • 资助金额:
    $ 39.91万
  • 项目类别:
13th International Conference on Lyme Borreliosis and Other Tick-borne Diseases
第十三届莱姆疏螺旋体病和其他蜱传疾病国际会议
  • 批准号:
    8459172
  • 财政年份:
    2013
  • 资助金额:
    $ 39.91万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8301247
  • 财政年份:
    2012
  • 资助金额:
    $ 39.91万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8466282
  • 财政年份:
    2012
  • 资助金额:
    $ 39.91万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8839960
  • 财政年份:
    2012
  • 资助金额:
    $ 39.91万
  • 项目类别:
A New Cytokine-Based Immunoassay for the Diagnosis of Lyme Disease
用于诊断莱姆病的新的基于细胞因子的免疫测定法
  • 批准号:
    8877395
  • 财政年份:
    2012
  • 资助金额:
    $ 39.91万
  • 项目类别:
T cell cytokine assay for the diagnosis of disseminated Lyme borreliosis
T 细胞细胞因子测定用于诊断播散性莱姆疏螺旋体病
  • 批准号:
    8058201
  • 财政年份:
    2011
  • 资助金额:
    $ 39.91万
  • 项目类别:

相似海外基金

Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
  • 批准号:
    10726417
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease
定义莱姆病肽聚糖诱导的病理生理学的宿主和病原体决定因素
  • 批准号:
    10566961
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome
自身抗体作为治疗后莱姆病综合征的预测标记
  • 批准号:
    10737996
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms
具有持续神经系统症状的莱姆病治疗后的神经影像学和血液标记物
  • 批准号:
    10745421
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
ImmunoPET Probes for the Imaging of Lyme Disease
用于莱姆病成像的免疫PET探针
  • 批准号:
    10802275
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
Determinants of Post-Treatment Phenotypes in Lyme Disease
莱姆病治疗后表型的决定因素
  • 批准号:
    10738012
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
Elucidating the contributions of c-di-GMP and PlzA to tick- and mammalian host-adaptation in Lyme disease spirochetes
阐明 c-di-GMP 和 PlzA 对莱姆病螺旋体蜱和哺乳动物宿主适应的贡献
  • 批准号:
    10739945
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts
异常肽聚糖片段的自然释放导致易感宿主持续出现莱姆病症状
  • 批准号:
    10736544
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
Unlocking serology’s secrets: harnessing novel immune biomarkers to predict Lyme disease progression and recovery
揭开血清学的秘密:利用新型免疫生物标志物来预测莱姆病的进展和恢复
  • 批准号:
    10737313
  • 财政年份:
    2023
  • 资助金额:
    $ 39.91万
  • 项目类别:
A novel Lyme disease vaccine
一种新型莱姆病疫苗
  • 批准号:
    10515700
  • 财政年份:
    2022
  • 资助金额:
    $ 39.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了